2MD., Department of Ophthalmology, Bafra State Hospital, Samsun, Turkey
3Asist. Dr., Ondokuzmayıs University Ophthalmology Department, Samsun, Turkey
4Professor, Ondokuzmayıs University Ophthalmology Department, Samsun, Turkey DOI : 10.37844/glauc.cat.2022.17.22 Purpose: In our study, we aimed to evaluate the visual outcomes of phacoemulsification and intraocular lens implantation in uveitis cases and to determine the risk factors for postoperative complications.
Materials and Methods: We retrospectively analyzed 53 eyes of 41 patients with uveitis who underwent phacoemulsification and intraocular lens implantation in our clinic between January 2013 and December 2018. The clinical features, uveitis etiology, surgical complications and the management of complications were evaluated in all patients.
Results: In 41 patients included, the mean age was 45.3±16.3 years (8-75 years) and the postoperative follow-up period was 23.2±18.4 months (6-70 months). The best corrected visual acuity (BCVA) was 1.37±0.57 logMAR at preoperative period, and 0.42±0.37 logMAR at postoperative month 6 (p<0.001). Postoperative BCVA was found poorer in patients followed with Behçet?s uveitis than those who underwent cataract surgery with other uveitis etiologies (p<0.001, 0.74±0.45 logMAR vs. 0.30±0.27 logMAR). Cystoid macular edema and posterior capsule opacification were observed in 10 (18.9% and 19 (35.1%) patients within the first six months after surgery, respectively. There was no correlation between preoperative steroid implantation and/or intraoperative triamcinolone acetonide injection to anterior chamber and the number of attacks (p>0.05).
Conclusions: Although cataract surgery is considered a safe and successful procedure in uveitis patients, postoperative visual outcomes may differ can in different uveitis etiologies. It should be kept in mind that the reduction in postoperative complication rates will yield better visual outcomes by determining the existing risk factors.
Keywords : Phacoemulsification, intraocular lens, cataract, uveitis